Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2025 年第 3 季持倉
持倉截至 2025/9/30，2025/11/14 申報。只含多頭部位，變化是跟 2025 年第 2 季比股數。
- 持股檔數
- 43
- 較 2025 年第 2 季 −12
- 總值
- $4.39 億
- 較 2025 年第 2 季 −$5,940 萬 (−11.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 3,204,184 | $1.26 億 | 28.7% | +1,461,282+83.8% | 加碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 1,600,899 | $6,448 萬 | 14.7% | +100,957+6.7% | 加碼 | 歷史 |
| MDTMedtronic plc | Stock | 190,600 | $1,815 萬 | 4.1% | +190,600 | 新進 | 歷史 |
| BSXBoston Scientific Corp | Stock | 164,300 | $1,604 萬 | 3.7% | −157,500−48.9% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 660,424 | $1,270 萬 | 2.9% | +308,300+87.6% | 加碼 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 257,600 | $1,162 萬 | 2.6% | +257,600 | 新進 | 歷史 |
| NTRANatera, Inc. | COM | 70,400 | $1,133 萬 | 2.6% | −128,900−64.7% | 減碼 | 歷史 |
| DHRDanaher Corp | Stock | 54,700 | $1,084 萬 | 2.5% | −35,000−39.0% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 510,000 | $1,030 萬 | 2.3% | −179,500−26.0% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 2,994,033 | $1,027 萬 | 2.3% | +1,135,437+61.1% | 加碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 1,127,186 | $972.8 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| PFEPfizer Inc | Stock | 366,400 | $933.6 萬 | 2.1% | +366,400 | 新進 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 18,900 | $916.7 萬 | 2.1% | −10,700−36.1% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 8,981,855 | $870.2 萬 | 2.0% | +1,504,600+20.1% | 加碼 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 248,100 | $760.9 萬 | 1.7% | −401,900−61.8% | 減碼 | 歷史 |
| MTSRMetsera, Inc. | COM | 140,500 | $735.2 萬 | 1.7% | +140,500 | 新進 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 17,800 | $614.6 萬 | 1.4% | −14,200−44.4% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 698,363 | $595.0 萬 | 1.4% | +455,201+187.2% | 加碼 | 歷史 |
| CORCencora, Inc. | Stock | 19,000 | $593.8 萬 | 1.4% | −13,800−42.1% | 減碼 | 歷史 |
| EHCEncompass Health Corp | COM | 41,900 | $532.2 萬 | 1.2% | −32,100−43.4% | 減碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 26,800 | $496.9 萬 | 1.1% | +26,800 | 新進 | 歷史 |
| CICigna Group | Stock | 16,600 | $478.5 萬 | 1.1% | +16,600 | 新進 | 歷史 |
| ABBVAbbVie Inc. | Stock | 19,800 | $458.4 萬 | 1.0% | +19,800 | 新進 | 歷史 |
| MCKMcKesson Corp | Stock | 5,800 | $448.1 萬 | 1.0% | −7,700−57.0% | 減碼 | 歷史 |
| CARLCarlsmed, Inc. | COM | 321,912 | $431.0 萬 | 1.0% | +321,912 | 新進 | 歷史 |
| KVUEKenvue Inc. | Stock | 265,200 | $430.4 萬 | 1.0% | +265,200 | 新進 | 歷史 |
| IMUXImmunic, Inc. | COM | 4,699,411 | $414.3 萬 | 0.9% | −916,400−16.3% | 減碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 214,400 | $404.1 萬 | 0.9% | −53,600−20.0% | 減碼 | 歷史 |
| EXASExact Sciences Corp | COM | 73,600 | $402.7 萬 | 0.9% | −281,400−79.3% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 306,000 | $360.2 萬 | 0.8% | −758,500−71.3% | 減碼 | 歷史 |
| RGENRepligen Corp | COM | 23,300 | $311.5 萬 | 0.7% | −83,200−78.1% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 144,000 | $307.3 萬 | 0.7% | +144,000 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 14,500 | $288.3 萬 | 0.7% | +14,500 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 140,300 | $287.2 萬 | 0.7% | +129,000+1,141.6% | 加碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 112,000 | $271.8 萬 | 0.6% | −297,400−72.6% | 減碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 3,350,528 | $258.0 萬 | 0.6% | +2,121,618+172.6% | 加碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 25,300 | $239.8 萬 | 0.5% | −66,700−72.5% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 297,500 | $217.8 萬 | 0.5% | +297,500 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 53,400 | $214.4 萬 | 0.5% | −54,491−50.5% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 40,500 | $192.3 萬 | 0.4% | −93,500−69.8% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 11,600 | $167.1 萬 | 0.4% | −47,400−80.3% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 134,566 | $88.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMRXImmuneering Corp | CLASS A COM | 90,900 | $63.6 萬 | 0.1% | +90,900 | 新進 | 歷史 |
2025 年第 2 季之後清倉（25 檔）
2025 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 2 季股數 | 2025 年第 2 季市值 | 2025 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| THCTenet Healthcare Corp | COM NEW | 106,000 | $1,866 萬 | 3.7% | 歷史 |
| DXCMDexcom Inc | COM | 210,500 | $1,837 萬 | 3.7% | 歷史 |
| HNGEHinge Health, Inc. | CL A | 322,344 | $1,668 萬 | 3.3% | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 27,100 | $1,473 萬 | 3.0% | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 94,500 | $986.5 萬 | 2.0% | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 228,600 | $841.0 萬 | 1.7% | 歷史 |
| OMDAOmada Health, Inc. | COM | 390,600 | $714.8 萬 | 1.4% | 歷史 |
| HUMHumana Inc | Stock | 27,600 | $674.8 萬 | 1.4% | 歷史 |
| OGNOrganon & Co. | Stock | 640,000 | $619.5 萬 | 1.2% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 140,000 | $604.5 萬 | 1.2% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 19,000 | $575.0 萬 | 1.2% | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,000 | $559.9 萬 | 1.1% | 歷史 |
| DOCSDoximity, Inc. | CL A | 60,000 | $368.0 萬 | 0.7% | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 33,800 | $319.7 萬 | 0.6% | 歷史 |
| QUREuniQure N.V. | SHS | 207,000 | $288.6 萬 | 0.6% | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 65,000 | $282.3 萬 | 0.6% | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 32,000 | $268.1 萬 | 0.5% | 歷史 |
| CAHCardinal Health Inc | Stock | 15,000 | $252.0 萬 | 0.5% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 140,000 | $244.3 萬 | 0.5% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $230.2 萬 | 0.5% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 232,000 | $217.6 萬 | 0.4% | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 39,000 | $184.1 萬 | 0.4% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 150,000 | $140.5 萬 | 0.3% | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 105,000 | $40.6 萬 | 0.1% | 歷史 |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 138,000 | $5.26 萬 | <0.1% | 歷史 |